Ledger.Open graph →
SEC Form D · Amendment · filed April 18, 2012

MERSANA THERAPEUTICS INC

Offering
$10.0M
Sold
$10.0M
Exemption
—
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

People & firms on this filing (16)

Burkhard Blank · Cambridge, MAExecThomas Beck · Cambridge, MADirectorTimothy B. Lowinger · Cambridge, MAExecNicholas G. Bacopoulos · Cambridge, MAExec · DirectorMartin Vogelbaum · Cambridge, MADirectorC. B. Clarke · Cambridge, MADirectorJoyce Tsang · Cambridge, MADirectorMichael Metzger · Cambridge, MAExecDavid Cooper · Greenwich, CTDirectorJeffrey T. Webber · SAN MATEO, CADirectorEos Mortar Rock Capital GP, LLC · New York, NYDirectorJim D. Denny · Lexington, KYExec · DirectorRichard A. Farrell · Houston, TXExecDesmond Wheatley · SAN DIEGO, CADirectorZahroof Mohamed · Houston, TXExecIrina Makkaveeva · Kensington, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗